Croom Medical has introduced Biofuse, a novel 3D printed lattice technology designed to enhance the performance and integration of orthopedic implants.
Croom Medical's Biofuse technology utilizes advanced 3D printing to create intricate lattice structures for orthopedic implants. This innovative approach aims to improve the biomechanical properties and biological integration of implants within the human body.
The Biofuse lattice is designed to mimic the porous structure of natural bone, promoting better osseointegration. This means that bone tissue can grow more readily into and around the implant, potentially leading to greater stability and a reduced risk of implant loosening over time.
The company states that this technology allows for the creation of patient-specific implants, tailored to the unique anatomy of each individual. This customization is a significant advantage over traditional implants, which are typically manufactured in standardized sizes and shapes.
By leveraging 3D printing, Croom Medical can precisely control the pore size, interconnectivity, and overall geometry of the lattice structure. This level of control enables the development of implants with optimized mechanical strength and biological responsiveness.
The development of Biofuse represents a significant step in orthopedic additive manufacturing. The use of 3D printed lattices for implants addresses key challenges in improving osseointegration and enabling patient-specific solutions. This aligns with the broader trend of using AM for personalized medical devices, potentially leading to better patient outcomes and reduced revision surgeries in orthopedics.
Edited by the news editor with AI from the original report — please refer to the original source.